Search results
Results From The WOW.Com Content Network
Dalteparin is used to prevent a type of blood clot called deep vein thrombosis (DVT) in people who have undergone a hip replacement or stomach surgery or who are not able to move as normal during or after a hospital stay. A DVT can lead to blood clots in the lungs (PE, pulmonary embolism).
Dalteparin is used to prevent deep venous thrombosis, a condition in which harmful blood clots form in the blood vessels of the legs. These blood clots can travel to the lungs and can become lodged in the blood vessels of the lungs, causing a condition called pulmonary embolism.
Dalteparin is a low molecular weight heparin (LMWH) with antithrombotic properties. This LMWH enhances the activity of antithrombin III and leads to the inhibition of several blood coagulation factors, including factor Xa and thrombin, in a dose-dependent manner.
Dalteparin sodium. Dalteparin is a low molecular weight heparin. It is marketed as Fragmin. Like other low molecular weight heparins, dalteparin is used for prophylaxis or treatment of deep vein thrombosis and pulmonary embolism to reduce the risk of a stroke or heart attack. [2]
Fragmin (dalteparin) is an anticoagulant (blood thinner), a type of heparin indicated to prevent ischemic complications in unstable angina and non-Q-wave myocardial infarction, when concurrently administered with aspirin therapy.
Indicated for extended treatment of symptomatic venous thromboembolism (VTE) (proximal DVT and/or PE), to reduce recurrence of VTE in adult patients with cancer. In these patients,...
Dalteparin is a low molecular weight heparin used for the prophylaxis of thrombotic events in certain patients and prevent acute cardiac ischemic events in patients with unstable angina and non-Q-wave myocardial infarction.